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Abstract
Background: Intra-articular corticosteroid injection in juvenile idiopathic arthritis (JIA) is often
associated with anxiety and pain. Recent reports advocate the use of nitrous oxide (NO), a volatile
gas with analgesic, anxiolytic and sedative properties.
Objective: To prospectively evaluate the effectiveness and safety of NO analgesia for intra-
articular corticosteroid injection in JIA, and to assess patients and staff satisfaction with the
treatment.
Methods: NO was administered to JIA patients scheduled for joint injection. The patient, parent,
physician and nurse completed visual-analog scores (VAS) (0–10) for pain, and a 5-point satisfaction
scale. Change in heart rate (HR) during the procedure was recorded in order to examine
physiologic response to pain and stress. Patient's behavior and adverse reactions were recorded.
Results: 54 procedures (72 joints) were performed, 41 females, 13 males; 39 Jewish, 13 Arab;
mean age was 12.2 ± 4.7 year. The median VAS pain score for patients, parents, physicians and
nurses was 3. The HR increased ≥ 15% in 10 patients. They had higher VAS scores as evaluated by
the staff. The median satisfaction level of the parents and staff was 3.0 and 5.0 respectively. Adverse
reactions were mild.
Conclusion: NO provides effective and safe sedation for JIA children undergoing intra-articular
injections.
Introduction
Intra-articular corticosteroid injection is one of the corner-
stones of treatment for children with juvenile idiopathic
arthritis (JIA), particularly oligoarthritis [1]. Major side
effects are few except for the pain and the anxiety that
accompanies the procedure.
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including conscious sedation using intravenous benzodi-
azepine or general anesthesia [2]. Recently the use of
nitrous oxide (NO) as a safe and effective sedation
method has been reported [3-6]. NO is a volatile gas with
analgesic, anxiolytic and sedative properties, mixed
together with oxygen. NO has been used for more than
200 years [7].
Few studies have reported on the safety and efficacy of NO
in JIA. Cleary et al, showed that a fixed mixture of oxygen
and NO, given using a self-delivery device was safe and
effective for intra-articular injection in JIA [8].
Using NO by continuous flow method facilitates its' use
in younger patients, and can also enable the administra-
tion of variable NO concentrations up to 70% [3].
Our study aim was to evaluate the effectiveness and safety
of NO analgesia for intra-articular corticosteroid injec-
tions in JIA, and to assess patients and staff satisfaction
with the treatment.
Patients and methods
NO was administered to healthy JIA patients older than 3
years of age who were scheduled for joint injection, and
whose parents consented to participate in the study. Since
this procedure requires cooperation patients younger than
3 years were not included in this study. They were injected
under general anesthesia. The institutional ethics commit-
tee approved the study.
There was no comparison group. The apparatus used to
administer NO was the MDM- Matrx N20 mixer® that
allows various concentration of NO to be used with a
minimum O2 level of 30%, and also has a non-rebreath-
ing circuit. NO was administered in the pediatric day unit
by a specially assigned pediatrician who underwent for-
mal training for sedation and a PALS course. Oxygen sat-
uration, heart rate (HR), and respiratory rate were all
constantly monitored and recorded by a team member
not participating in the injection itself. NO concentration
was gradually increased up to a level of 30–50% that was
then maintained during the entire procedure (no age
related differences in NO concentration). EMLA (Astra-
Zeneca, Wilmington, DE) was placed in all patients at
least one hour before the procedure. Patients were not
restrained, and when possible the mask was self held. At
the end of the procedure 100% oxygen was administered
for 3–5 minutes.
Assessment of the procedural pain was made by the
patient, parent(s), participating nurse and physician using
an age specific visual analog score (VAS) with a scale of 0–
10 [9]. The satisfaction of the parents and staff was also
assessed by a Likert scale, with a score of 0–5 (5 is best).
All adverse effects were recorded and scored, as was
patient behavior during the procedure.
Statistics
Data analysis was performed using standard software (Sig-
mastat). One-way analysis of variance on ranks was used
to compare between VAS scores of the patients, parents
and staff. Rank sum test was used to compare the patients
with and without a significant increase in HR during the
procedure.
Results
54 procedures (72 joints) were performed in 43 patients,
31 females, 12 males; 32 Jewish, 11 Arab; mean age was
12.5 ± 4.8 years (range 3.7–18). Twenty of the patients
were under 10 years of age and twelve were under age 7
years. Six patients had 2 separate procedures, one had 3,
and another had 4 procedures. The majority were injec-
tions of large lower extremity joints, only 3 were of small
joints of the hands.
All parents, 93% of physicians and 89% of nurses
reported that NO eased the child's pain, and made the
procedure easier to perform. The median pain VAS for the
patients, parents, physicians and nurses was 3 (Figure 1).
There were no significant differences between the differ-
ent reporter groups. There was no difference in the VAS
score between older and younger children.
Pain VASFigure 1
Pain VAS. Median pain VAS for the patients, parents, physi-
cians and nurses. VAS- Visual analog scale.
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significantly higher VAS as assessed by the physicians (p =
0.006) and nurses (p = 0.010) (Table 1). Nurses and phy-
sicians were satisfied with the treatment (Table 2, median
level = 5.0). Parents were slightly less satisfied with a
median satisfaction level of 3.0 (Table 2). When we com-
pared the VAS between the first and the following injec-
tions for those patients who had several injections, no
significant differences were found. Recovery time from the
procedure was immediate. Adverse reactions were mild,
vomiting in 2 patients and shivering in one patient that
resulted in discontinuation of NO. No patient had a
decrease in oxygen saturation levels. No other severe
adverse events were observed.
Discussion
Our study reemphasizes the efficacy of NO as an optional
sedation for JIA intra-articular injections with low VAS
scales assigned by patients, parents and the medical staff.
We found a good correlation between the VAS recorded by
the medical staff and objective physiological parameters
such as the increase in the HR. This finding can be used for
better pain monitoring during the procedure.
Children with JIA suffer from pain from procedures
including joint injections, and pain related to their arthri-
tis. We offer this procedure for all children, even adoles-
cents, as NO is easy to use in our ambulatory service.
Effectively reducing procedural pain can reduce the anxi-
ety with each procedure which itself can exacerbate arthri-
tis pain [10]. Pain reduction is increased if undertaken
from the first painful procedure. Among children with
newly diagnosed cancer, those who had inadequate anal-
gesia during the first bone marrow aspiration or lumbar
puncture had significantly increased distress during subse-
quent procedures when compared to children who
received analgesia during the first procedure [11].
Relaxation before and a comfortable atmosphere during
sedation, make the procedure easier to perform. It is pos-
sible that better relaxation techniques used by Cleary et al.
explain their lower VAS scores (median VAS of 1, mean of
2.1) than in our study [2]. Cleary et al frequently used a
play specialist prior to the procedure (personal knowl-
edge). While not examined in this study it is also possible
that their lower scores are partially explained by tempera-
ment differences between their British subjects and our
subjects. In our study there was no significant difference
between Arab and Jewish patients.
In the group of children who underwent more than one
procedure (N = 8) we did not demonstrate less pain or
stress in subsequent injections despite our assumptions
from the childhood cancer data [11]. The small sample
size of this subgroup was not of sufficient power for this
analysis.
As in other studies [5,11,12], NO was safe with no major
side effects. When comparing NO to other sedation
options such as IV midazolam or general anesthesia, NO
stands as a safer option. Moreover, midazolam has no
analgesic property so for painful procedures it is com-
monly administered together with an opoid, a practice
that may decrease midazolams' safety profile [13]. It is
also easier to schedule a patient for NO sedation as com-
pared to the use of general anesthesia.
Conclusion
NO provides an effective and safe sedation for children
with JIA undergoing intra-articular injections.
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Table 1: Pain VAS in the low vs. high HR change groups.
Patient VAS Parent VAS Physician VAS* Nurse VAS*
Low ∆HR 2.75 3.00 2.25 3.00
High ∆HR 5.50 5.00 4.50 5.00
VAS: Visual analog scale; HR: heart rate
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Table 2: Procedure satisfaction
Parent Physician Nurse
Median Likert Score 3 5 5
Mean Likert Score ± SD 3.0 ± 2.4 4.1 ± 1.3 4.3 ± 1.2
Likert score of 0–5 (5 is best)
SD: Standard deviationPage 4 of 4
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